Plasmatic level of neurosin predicts outcome of mild cognitive impairment.

Item

http://www.wikidata.org/entity/Q21202048

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Plasmatic level of neurosin predicts outcome of mild cognitive impairment

@nl

Plasmatic level of neurosin predicts outcome of mild cognitive impairment.

@ast

Plasmatic level of neurosin predicts outcome of mild cognitive impairment.

@en

Plasmatic level of neurosin predicts outcome of mild cognitive impairment.

@en-gb

type

Item

label

Plasmatic level of neurosin predicts outcome of mild cognitive impairment

@nl

Plasmatic level of neurosin predicts outcome of mild cognitive impairment.

@ast

Plasmatic level of neurosin predicts outcome of mild cognitive impairment.

@en

Plasmatic level of neurosin predicts outcome of mild cognitive impairment.

@en-gb

prefLabel

Plasmatic level of neurosin predicts outcome of mild cognitive impairment

@nl

Plasmatic level of neurosin predicts outcome of mild cognitive impairment.

@ast

Plasmatic level of neurosin predicts outcome of mild cognitive impairment.

@en

Plasmatic level of neurosin predicts outcome of mild cognitive impairment.

@en-gb

P1476

Plasmatic level of neurosin predicts outcome of mild cognitive impairment

@en

P2093

Alfonso Lopez-Muñiz

http://www.w3.org/2001/XMLSchema#string

Ana Suarez

http://www.w3.org/2001/XMLSchema#string

Carmen Gutierrez

http://www.w3.org/2001/XMLSchema#string

Manuel Menendez-Gonzalez

http://www.w3.org/2001/XMLSchema#string

Maria Teresa Calatayud

http://www.w3.org/2001/XMLSchema#string

Marta Martinez-Rivera

http://www.w3.org/2001/XMLSchema#string

Renee Ribacoba

http://www.w3.org/2001/XMLSchema#string

P2860

Under-representation of developing countries in the research literature: ethical issues arising from a survey of five leading medical journals

The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry

Proteinase-activated receptors, targets for kallikrein signaling

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

Global prevalence of dementia: a Delphi consensus study

Mild cognitive impairment: clinical characterization and outcome

Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease

FUNCTIONAL EVALUATION: THE BARTHEL INDEX

Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients

Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1755-7682-1-11

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pablo Perez-Pinera

Patricia Castro-Santos

P577

2008-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5231142

http://www.w3.org/2001/XMLSchema#string

P698

18620574

http://www.w3.org/2001/XMLSchema#string

P932

2475518

http://www.w3.org/2001/XMLSchema#string